)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Bioextrax
Bioextrax (BIOEX) investor relations material
Bioextrax Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary25 Aug, 2026
Executive summary
Focus on commercializing bioplastics and protein/microfiber technologies from renewable resources, with licensing as the core business model.
Signed a major license agreement in West Asia for PHBV production, with significant revenue potential.
Entered a three-year framework agreement with a global top-3 chemical company for joint innovation in Home & Personal Care.
Advanced several customer projects, including with a leading confectionery producer and Lantmännen.
Financial highlights
Net sales for Q2 2026: 130 tkr (448 tkr Q2 2025); H1 2026: 374 tkr (527 tkr H1 2025).
Operating loss for Q2 2026: -4,949 tkr (-4,446 tkr Q2 2025); H1 2026: -9,278 tkr (-8,435 tkr H1 2025).
Net result per share Q2 2026: -0.10 SEK (-0.11); H1 2026: -0.20 SEK (-0.21).
Cash flow for H1 2026: 3,460 tkr (-6,473 tkr H1 2025); cash position at June 30, 2026: 7,391 tkr.
Equity per share at June 30, 2026: 0.25 SEK (0.53 SEK Dec 31, 2025); equity ratio: 82.7%.
Outlook and guidance
Ongoing commercialization efforts with multiple potential license agreements in progress.
Additional financing may be required if new commercial agreements are not secured in the next 12 months.
Management is actively evaluating financing options and expects to secure necessary funding.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bioextrax
- Major PHBV licensing deal and improved cash flow mark a pivotal Q1 2026.BIOEX
Q1 2026 - Sales grew but losses persisted; major licensing deals and new funding secured.BIOEXQ4 2025
- Net sales up 92% year-over-year, with key customer projects and a 13.3 MSEK rights issue announced.BIOEXQ3 2025
- Improved financials and key project advances support a positive outlook for commercialization.BIOEXQ2 2025
- Operating losses narrowed and liquidity improved, supported by new licensing deals and capital raises.BIOEXQ3 2024
- Licensing progress and new capital position Bioextrax for commercial breakthroughs in bioplastics.BIOEXQ2 2024
- Sales growth and improved margins signal progress in Bioextrax's commercialization.BIOEXQ1 2025
- Cost reductions and new capital support Bioextrax’s commercial push in bioplastics.BIOEXQ4 2024
Next Bioextrax earnings date
Q3 202619 Nov, 2026
Bioextrax
Next Bioextrax earnings date
Q3 202619 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage